In the last day or so the shares of the ConvaTec Group (LON:CTEC) has been one of the standout performers, climbing nearly 6% following the medical products company announcing a chunky share buyback programme of up to $300m. ConvaTec operates in four chronic care categories, which have market growth rates varying between 4-8% p.a. It sells over 900m high-quality consumable products annually for a diverse range of chronic conditions and are among a small number of leaders in the categories in which we operate. The group expects to consistently grow revenues faster than each m...
